Literature DB >> 28248802

Repeat head imaging in blunt pediatric trauma patients: Is it necessary?

E Patricia Hill1, P J Stiles, Jared Reyes, R Joseph Nold, Stephen D Helmer, James M Haan.   

Abstract

BACKGROUND: Children with confirmed brain injury usually undergo follow-up computed tomography (CT) scan of the head within 24 hours of admission. To date, no evidence exists to validate the diagnostic or therapeutic value of these repeat CTs. The purpose of this study was to (1) evaluate progression of traumatic brain injuries, (2) determine if routine repeat imaging changes management, and (3) compare the efficacy of recognizing worsening hemorrhage with serial neurological examination versus repeat imaging.
METHODS: A 5-year retrospective review was conducted of all patients aged under 18 years with blunt traumatic head injury (n = 95). Data included demographics, type and size of intracranial hemorrhage, exam findings, diagnostic and management changes, and hospital outcomes.
RESULTS: Most patients (68.4%) had at least one repeat CT; of these, 67.7% (n = 44) showed no change or reduced hemorrhage. In only one patient did a repeat CT scan result in a surgical procedure; however, that CT scan was prompted by a change in neurological status. Among patients with more than two repeat head CTs, 42.9% led to a change in management, most frequently an additional CT scan. Presence of neurological symptoms was associated with having repeat CT scans (p = 0.025). Changes in Glasgow Coma Scale score were associated with increased hemorrhage (p = 0.012) but not repeat scans (p = 0.496). In the majority of cases, increased hemorrhage only resulted in an additional head CT and prolonged intensive care unit stay. Excluding patients who arrived with brain death, there was no difference in mortality between patients with and without repeat imaging.
CONCLUSION: Findings from this study support a selective approach for repeating head CTs with emphasis on changes in neurological symptoms and Glasgow Coma Scale score. Prospective studies on timing and indications for repeat CT scans are needed to support development of clinical guidelines. LEVEL OF EVIDENCE: Therapeutic study, level III.

Entities:  

Mesh:

Year:  2017        PMID: 28248802     DOI: 10.1097/TA.0000000000001406

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  5 in total

1.  North American survey on the post-neuroimaging management of children with mild head injuries.

Authors:  Jacob K Greenberg; Donna B Jeffe; Christopher R Carpenter; Yan Yan; Jose A Pineda; Angela Lumba-Brown; Martin S Keller; Daniel Berger; Robert J Bollo; Vijay M Ravindra; Robert P Naftel; Michael C Dewan; Manish N Shah; Erin C Burns; Brent R O'Neill; Todd C Hankinson; William E Whitehead; P David Adelson; Mandeep S Tamber; Patrick J McDonald; Edward S Ahn; William Titsworth; Alina N West; Ross C Brownson; David D Limbrick
Journal:  J Neurosurg Pediatr       Date:  2018-10-26       Impact factor: 2.375

2.  Delayed evolving epidural hematoma in the setting of a depressed skull fracture: A case report and review of the literature.

Authors:  Arthur Berg; Brett Voigt; Sanjeev Kaul
Journal:  Trauma Case Rep       Date:  2019-06-27

3.  Trends and variation in repeat neuroimaging for children with traumatic intracranial hemorrhage.

Authors:  Pradip P Chaudhari; Jose A Pineda; Richard G Bachur; Robinder G Khemani
Journal:  J Am Coll Emerg Physicians Open       Date:  2021-03-06

4.  Role of Routine Repeat Head CT for Pediatric Patients under 2 Years Old with Mild-to-moderate Traumatic Brain Injury.

Authors:  Shu Utsumi; Shima Ohnishi; Shunsuke Amagasa; Ryuji Sasaki; Satoko Uematsu; Mitsuru Kubota
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-12-08       Impact factor: 1.742

5.  Radar based technology for non-contact monitoring of accumulation of blood in the head: A numerical study.

Authors:  Moshe Oziel; Rafi Korenstein; Boris Rubinsky
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.